Cadmium body burden, hypertension and changes in blood pressure over time: Results from a prospective cohort study in American Indians
This study assesses the association between baseline urinary cadmium and longitudinal changes in blood pressure in American Indian communities. Cadmium was measured in 3,047 baseline urine samples from Strong Heart Study participants from three geographic areas. Longitudinal changes in blood pressure across three study visits (1989-99) were modeled using linear mixed models by baseline log urinary cadmium to creatinine ratio. (Source: Journal of the American Society of Hypertension)
Source: Journal of the American Society of Hypertension - March 9, 2018 Category: Cardiology Authors: Clare Oliver-Williams, Annie Green Howard, Ana Navas-Acien, Barbara V. Howard, Maria Tellez-Plaza, Nora Franceschini Tags: Research Article Source Type: research

Inverted U-Shaped Curve Relationship between Red Blood Cell Distribution Width and Hypertension in a Large Health Check-Up Population in China
This study was aimed at investigating the relationship between red blood cell distribution width (RDW) and hypertension in a large health check-up population in China. (Source: Journal of the American Society of Hypertension)
Source: Journal of the American Society of Hypertension - March 9, 2018 Category: Cardiology Authors: Mingfei Jiang, Xiaojuan Zha, Zewei Wu, Xinying Zhu, Wenbo Li, Huan Wu, Jun Ma, Shuyi Wang, Yufeng Wen Tags: Controversies in Hypertension Source Type: research

Editorial Board
(Source: Journal of the American Society of Hypertension)
Source: Journal of the American Society of Hypertension - March 1, 2018 Category: Cardiology Source Type: research

Table of Contents
(Source: Journal of the American Society of Hypertension)
Source: Journal of the American Society of Hypertension - March 1, 2018 Category: Cardiology Source Type: research

Instructions for Authors
(Source: Journal of the American Society of Hypertension)
Source: Journal of the American Society of Hypertension - March 1, 2018 Category: Cardiology Source Type: research

Notice of concern
Concern has been raised regarding the following article published in the Journal of the American Society of Hypertension (JASH): (Source: Journal of the American Society of Hypertension)
Source: Journal of the American Society of Hypertension - March 1, 2018 Category: Cardiology Tags: Letter to the Editor Source Type: research

From the Editor
The 2017 ACC/AHA blood pressure guideline lowers the threshold used to define hypertension to a systolic blood pressure of 130  mm Hg or higher or a diastolic pressure of 80 mm Hg or higher.1 In addition, the new guideline lowers the systolic blood pressure level that qualifies for treatment for many adults. A consequence of the lowered thresholds for defining and treating hypertension is a sharp increase in the number of people with hypertension in the U.S. and the number who qualify for drug treatment. (Source: Journal of the American Society of Hypertension)
Source: Journal of the American Society of Hypertension - March 1, 2018 Category: Cardiology Authors: Daniel Levy Tags: Editor's Page Source Type: research

Editorial Board
(Source: Journal of the American Society of Hypertension)
Source: Journal of the American Society of Hypertension - March 1, 2018 Category: Cardiology Source Type: research

Table of Contents
(Source: Journal of the American Society of Hypertension)
Source: Journal of the American Society of Hypertension - March 1, 2018 Category: Cardiology Source Type: research

Instructions for Authors
(Source: Journal of the American Society of Hypertension)
Source: Journal of the American Society of Hypertension - March 1, 2018 Category: Cardiology Source Type: research

Notice of concern
Concern has been raised regarding the following article published in the Journal of the American Society of Hypertension (JASH): (Source: Journal of the American Society of Hypertension)
Source: Journal of the American Society of Hypertension - March 1, 2018 Category: Cardiology Source Type: research

From the Editor
The 2017 ACC/AHA blood pressure guideline lowers the threshold used to define hypertension to a systolic blood pressure of 130  mm Hg or higher or a diastolic pressure of 80 mm Hg or higher.1 In addition, the new guideline lowers the systolic blood pressure level that qualifies for treatment for many adults. A consequence of the lowered thresholds for defining and treating hypertension is a sharp increase in the number of people with hypertension in the U.S. and the number who qualify for drug treatment. (Source: Journal of the American Society of Hypertension)
Source: Journal of the American Society of Hypertension - March 1, 2018 Category: Cardiology Authors: Daniel Levy Tags: Editor's Page Source Type: research

Can a polypill one single tablet combat different cardiovascular risk factors?
Polypharmacy is defined as the use of two or more drugs simultaneously. Cardiovascular drugs and antihypertensives are commonly prescribed for treatment of cardiovascular disease (CVD), especially in elderly patients. Recent studies in patients with a history of CVD demonstrated that the fixed-dose combination of cardiovascular drugs in a polypill retain their individual efficacy, safety, and tolerability, thus have the potential to improve medication adherence and multiple risk factor control, thereby improving patient outcomes in secondary cardiovascular prevention. (Source: Journal of the American Society of Hypertension)
Source: Journal of the American Society of Hypertension - February 27, 2018 Category: Cardiology Authors: Talma Rosenthal Tags: Review Article Source Type: research

Can a Polypill One Single Tablet Combat Different Cardiovascular Risk Factors
Polypharmacy is defined as the use of two or more drugs simultaneously. Cardiovascular drugs and antihypertensives are commonly prescribed for treatment of cardiovascular disease (CVD), especially in elderly patients. Recent studies in patients with a history of CVD demonstrated that the fixed-dose combination of cardiovascular drugs in a polypill retain their individual efficacy, safety and tolerability, thus have the potential to improve medication adherence, and multiple risk factor control, thereby improving patient outcomes in secondary cardiovascular prevention. (Source: Journal of the American Society of Hypertension)
Source: Journal of the American Society of Hypertension - February 27, 2018 Category: Cardiology Authors: Talma Rosenthal Tags: Review Article Source Type: research